Fibrocell Science, Inc. FCSC was a big mover last session, as its shares rose almost 14% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the recent uptrend for the company as the stock is now up almost 45% in the past one-month time frame.
The company has seen one positive estimate revision in the last 30 days, its Zacks Consensus Estimate moved higher over the same time frame, suggesting more solid trading ahead. So make sure to keep an eye on this stock going forward to see if yesterday’s jump can turn into more strength down the road.
Fibrocell Science currently carries a Zacks Rank #3 (Hold), while its Earnings ESP is negative.
Fibrocell Science Inc Price
Fibrocell Science Inc Price | Fibrocell Science Inc Quote
A top-ranked stock worth considering in the Medical - Biomedical and Genetics space is VIVUS, Inc. VVUS, sporting a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
Looking for Stocks with Skyrocketing Upside?
Zacks has just released a Special Report on the booming investment opportunities of legal marijuana.
Ignited by new referendums and legislation, this industry is expected to blast from an already robust $6.7 billion to $20.2 billion in 2021. Early investors stand to make a killing, but you have to be ready to act and know just where to look.
See the pot trades we're targeting>>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Click for Free VIVUS, Inc. (VVUS) Stock Analysis Report >>
Click for Free Fibrocell Science Inc (FCSC) Stock Analysis Report >>
To read this article on Zacks.com click here.
Zacks Investment Research